Clinical Trial Update: Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial assessing the safety and efficacy of DIABECELL in patients with Type 1 diabetes mellitus. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• DIABECELL

Snippet

Sponsor: Living Cell Technologies | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED